Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. cities
Shuchi Anand(Stanford University), Alka M. Kanaya(San Francisco General Hospital), Nikhil Tandon, Kalpana Singh(Hamad Medical Corporation), Ruby Gupta(All India Institute of Medical Sciences), Yuanchao Zheng(Stanford University), Viswanathan Mohan(Madras Diabetes Research Foundation), Maria E. Montez‐Rath(Stanford University), Glenn M. Chertow(Stanford Health Care), K.M. Venkat Narayan(Emory University), Vamadevan S. Ajay(XLIM), Priti Gupta(Public Health Foundation of India), Rajendra Pradeepa, Namratha R. Kandula(Northwestern University), Roopa Shivashankar(Indian Council of Medical Research), Dimple Kondal(Centre for Chronic Disease Control), Mohammed K. Ali(Emory University), Dorairaj Prabhakaran(Dignity Health)
Cited by 27
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|8.4k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k